1,4-DIHYDROPYRIDINE COMPOUND

Abstract: 1,4-Dihydropyridine compound having the general for­ mula: wherein R is 2-(5,6-dihydro-p-dioxinyl), 2-(3,5-dimethyl-5,6-­ dihydro-p-dioxinyl), 2-(3-methyl-5,6-dihydro-p-dioxinyl), 2-­ (3-methoxymethyl-5,6-dihydro-p-dioxinyl), 5-(3,4-dihydro-­ 2H-pyranyl), or 2-(5,6-dihydro-1,4-dithiinyl); R¹ and R² are independently a cyano group, an acetyl group, or a substi­ tuted oxycarbonyl group having the general formula COOR⁴ wherein R⁴ is a methyl, isopropyl, allyl, propargyl, methoxy­ methyl, 2-methoxymethyl, or 1-methyl-2-methoxymethyl group provided that both R¹ and R² are nor -COOCH₃ in the case of R being 2-(5,6-dihydro-p-dioxinyl) and R³ being hydrogen; and R³ is hydrogen or a methoxymethyl group. This 1,4-dihydropyridine compound has a remarkable liver pro­ tective action and a low toxicity.

Description: 1,4-DIHYDROPYRIDINE COMPOUND The present invention relates to a novel 1,4dihydropyridine compound having the general formula: EMI1.1 oxycarbonyl group having the general formula COOR4 wherein R4is a methyl -CH3 , isopropyl -CH(CH3)2 allyl -CH2-CH=CH2 , propargyl -CH2-C--CH, methoxymethyl -CH2 OC H3 , 2-methoxyethyl -CH2CH 2OCH3 , or l-methyl-2- methoxyethyl -CH(CH3)CH20CH3 group, provided that both R1 and R2 are not -COOCH3 in the case of R being 2-(5,6-dihydro-p-dioxinyl) and R3 being hydrogen; and R3 is hydrogen or a methoxymethyl group. The 1,4-dihydropyridine compounds having the above-mentioned general formula [I] are novel compounds which have not been reported in any literature. These compounds have a remarkable liver protective action and a low toxicity, as mentioned hereinbelow. Accordingly, these compounds are useful as medicine for the treatment of hepatic disease. Especially, the l,-dihydropyridine compounds having the general formula (I) in which R is 22-(5,6-dihydro-p-dioxinyl), 2-(3,5-dimethyl-5,6-dihydrop-dioxinyl), 2-(3-methyl-5,6-dihydro-p-dioxinyl), or 2-(3-methoxymethyl-5,6-dihydro-p-dioxinyl), more especially 2- (5 ,6-dihydro-p-dioxinyl), 2- (3 ,5-dimethyl- 5 ,6-dihydro-p-dioxinyl), or 2-(3-methyl-5,6- ihydro-p- dioxinyl), or R1 and R2 are independently an acetyl, methyloxycarbonyl, methoxymethyloxycarbonyl, or 2-methoxyethyloxycarbonyl group are those having an especially remarkable liver protective acticn. Examples of these preferable 1,4-dihydropyridine compounds are 3,5-diacetyl-4-[2-(5,6-dihydroi-p-dioxinyl)]-2,6-dimethyl1,4-dihydropyridine, bis(2-methioxyethyl) 4-[2-(5,6- dihydro-p-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine3,5-dicarboxylate, methyl 5-acetyl-4-[2-(5,6-dihydro-pdioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3carboxylate, 3,5-diacetyl-2,6-dimethyl-4-[2-(3,5dimethyl-5,6-dihydro-p-dioxinyl)]-1,4-dihydropyridine, 3,5-diacetyl-4-[5-(3,4-dihydro-2H-pyranyl)]-2,5-dimethyl1,4-dihydropyridine, bis (methoxymethyl) 4-[2- (5,6- dihydro-p-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine3,5-dicarboxylate, 3,5-diacetyl-2,6-dimethyl-4-[2-(3methyl-5,6-dihtydro-p- dioxinyl)]-1,4-dihydropyridine, 3,5-diacetyl-4-[2-(5,6-dihydro-p-dioxinyl)]-1 methoxymethvl-2,6-dimethyl-1,4-dihydropyridine, bis(methoxymethyl) 2,6-dimethyl-4-[2-(3,5-dimethyl 5,5-dihydro-p- ioxinyl)l-1,4-dihyacpyridine-3,5- dicarboxlate, and bis (methoxymethyl) 4-[2-(5,6-dihydro- p-dioxinyl)l-l-methoxyme-hyl-2,6-dimethyl-1,4-aihydro- pyridine-3,5-dicarboxylate. The 1,4-dihydropyridine compounds of the present invention having the general formula: EMI2.1 wherein R is the same as defined above, and R1 and R2 are independently a cyano group, an acetyl group, or a substituted oxycarbonyl group having the general formula COOR wherein R is a methyl, isopropyl, allyl, propargyl, 2-methoxyethyl, or l-methyl-2-methoxyethyl group provided that both R1 and R2 are not -COOCH3 in the case of R being 2-(5,6-dihydro-p-dioxinyl) and R3 being hydrogen, can be prepared by reacting (i) an aldehyde having the general formula: R-CHO (ski) wherein R is the same as defined above, (ii) a compound having the general formula: EMI3.1 wherein R1 is the same as defined in the formula (I'), and (iii) a compound having the general formula: : EMI3.2 wherein R2 is the same as defined in the formula (I') together in the presence, or in the absence, of an organic solvent upon heating at a temperature of 600C to 1700C, preferably under a reflux condition. Furthermore, the 1,4-dihydropyridine compounds of the present invention having the general formula: EMI3.3 wherein R is the same as defined above, R3 is hydrogen, and R1 and R2 are a methoxymethyl oxyzarbonyl group (-COOCH2OCH3) can be prepared by reacting (iv) an aldehyde having the above-mentioned general formula (II), (v) a compound having the genral formula: EMI4.1 and (vi) a compound having the general formula: EMI4.2 together in the presence, or in the absence, of an organic solvent to form a compound having the general formula: EMI4.3 wherein R is the same as defined above,and then hydrolyzing the compound (VII). The resultant hydrolyzate of the compound (VII) is reacted with an approximate stoichiometric amount of chloromethyl methyl ether to form the 1,4-dihydropyridine compounds of the general formual (I") in which R3 is hydrogen. The i,4-dlhydropyridine compounds having the general formula (I') or (Ill) in which R3 is -CH2OCH3 can be prepared by reacting the 1,4-dihydropyriaine compounds having the general formual (I') or (I") in which R3 is hydrogen with chloromethyl methyl ether. The preparation method of the 1,4-dihydropyridine compound havinq the qeneral formula (T) wherein R3 is hydrogen from 2-formyl-p-dioxene, i.e., EMI4.4 in the aldehyde having the general formula (II), is further explained in detail hereinbelow. (a) In the case of both RÚ and Rê in the general formula (I) being a cyano group, the desired compound can be prepared by reacting 2-formyl-p-dioxene with and f3-aminocrotononitrile in, for example, acetic acid, as follows: Method 1 EMI5.1 Desired compound (b) In the case of R1 being a cyano group and R2 being an acetyl group in the general formula (I) the desired compound can be prepared by reacting 2-formyl-pdioxene, B-aminocrotononitrile, and acetylaceton in the presence, or in the absence, of an organic solvent such as ethanol, n-propanol, isopropanol, or pyridine upon heating at a temperature of 60"C to 1700C, preferably under a reflux condition as follows: : Method 2 EMI5.2 Desired compound (c) In the case of RÚ being a cyano group and Rê being a substituted oxycarbonyl group in the general formula (I), the desired compound can be prepared by reacting 2-formyl-p-dioxene, ss-aminocrotononitrile, and acetoacetic ester in the presence, or in the absence, of an organic solvent as used in method 2 upon heating at a temperature of 600C to 1700C, preferably under a reflux condition as follows: : Method 3 EMI5.3 Desired compound (d) In the case of both RÚ and Rê being acetyl groups in the general formula (I'), the desired compound can be prepared by reacting 2-formyl-p-dioxene, 4-amino3-penten-2-one, and acetyl acetone in the presence, or in the absence, of an organic solvent as mentioned above upon heating at a temperature of 60"C to 1700C or under a reflux condition as follows: : Method 4 EMI6.1 Desired compound (e) In the case of R1 being an acetyl group and R2 being a substituted oxycarbonyl group in the general formula (I'), the desired compound can be prepared by reacting 2-formyl-p-dioxene, 4-amino-3-penten-2-one, and acetoacetic ester in the presence, or in the absence, of the above-mentioned organic solvent upon heating at a temperature of 60"C to 1700C or under a reflux condition as shown in the following method 5, or by first reacting 2-formyl-p-dioxene and acetoacetic ester to form 1-[2 (5,6-dihydro-p-dioxinylUl-3-oxo-1-butene-2-carboxylic ester, which is in turn reacted with 4-amino-3-penten2-one in the presence, or in the absence, of the above-mentioned organic solvent upon heating at a temperature of 600C to 1700C or under a reflux condition as shown in the following method 6. Method 5 EMI6.2 Method 6 EMI6.3 (f) In the case of both RÚ and Rê being substituted oxycarbonyl groups except for a methoxymethyl oxycarbonyl group in the above-mentioned general formula (I'), the desired compound can be prepared by reacting 2-formyl-p dioxene, S-amino crotonic ester, and acetoacetic ester in the presence, or in the absence, of the above-mentioned organic solvent upon heating at a temperature of 600C to 1700C or under a reflux condition as shown in the following method 7, or by reacting 1-[2-(5,6-dihydro-p- dioxinyl)]-3-oxo-1-butene-2-carboxylic acid ester obtained in the same manner as in the method 6 with ss-aminocrotonic ester in the presence, or in the absence, of the above-mentioned organic solvent upon heating at a temperature of 60"C to1700C or under a reflux condition as shown in the following method 8, or by reacting 2-formyl-p-dioxene, acetoacetic ester, and aqueous ammonia in the presence, or in the absence, of the above-mentioned organic solvent upon heating at a temperature of 600C to 1700C or under a reflux condition as shown in the following method 9. Method 7 EMI7.1 (g) In the case of RÚ and/or Rê being a methoxymethyl oxycarbonyl group or groups in the general formula (I"), the 1,4-dihydropyridine compound having the general formula (I') in which RÚ and/or Rê are 2-cyanoethyl oxycarbonyl groups is first prepared by any one of the above-mentioned methods 3 and 5 to 9 and, then, the resultant compound (X) is hydrolyzed by, for example, sodium hydroxide. The resultant hydrolysate (XI) is reacted with chloromethyl methyl ether in, for example, an organic solvent such as dimethyl formamide to form the desired compound (XTI). EMI8.1 (h) In the case of R3 being a methoxymethyl group in the general formula (I') or (It'), the 1,4-dihydropyridine compound having the general formula (I') or (I") in which R3 is hydrogen is first prepared by any one of the above-mentioned methods 1 to 9 and, then, the resultant compound is reacted with chloromethyl methyl ether in the presence of, for example, sodium hydride in an organic solvent as follows. Method 10 EMI8.2 The above-mentioned 1 ,4-dihydropyridine compounds [I] can also be prepared by the known reactions set forth in, for example, Japanese Examined Patent Publication (Kokoku) Nos. 46-40625 and 56-37225 and Japanese Unexamined Patent Publication (Kokai) Nos. 51-108075, 53-92784, 54-103876, 55-64570, 55-89281, and 58-159490. The above-mentioned starting compounds used in the above-mentioned reactions are almost of known compounds which are readily purchased, or can be readily prepared by those skilled in the art. For instance, B-amino- crotono nitrile, acetoacetic esters, 6-aminocrotonic esters, acetylacetone, and 4-amlno-3-penten-2-one are those which are conventionally used as a starting compound for the production of 1,4-dihydropyridine compounds and which are commercially available on the market. The 2-formyl-p-dioxene among the aldehydes shown in formula (II) can be prepared from p-dioxene via 2-ethoxy-3-diethoxymethyl-p-dioxane according to a method describe in, for examples M. C. Shostakovskii, Izvest. Akad. Nauk. S.S.S.R. Otdel. Khim. Nauk., 1685, (1961). Furthermore, 5-formyl-3,4-dihydro-2H-pyran can be prepared according to a method described in, for example, L. Skatteboel, J. Org. Chem. 35(9), 3200-3201, (1970). Furthermore, tyhe 2-formyl-3,5-dimethyl-p-dioxene, 2-formyl-3-methyl-p-dioxene, and 2-formyl-1,4-dithiiene can be prepared by using, as the starting materials, 2,6-dimethyl-p-dioxene, 2-methyl-p-dioxene, and 1,4dithiene, respectively, by reacting the starting materials with dimethylformamide or the like and phosphorus oxychloride, followed by, for example, the hydrolysis of the resultant products. The 2-formyl-3methoxymethyl-p-dioxene can be prepared by synthesizing 2-methoxymethyl-p-dioxene from 2-formyl-p-dioxene vie 2-hydroxymethyl-p-dioxene, and reacting the material with DMF or the like and POC13 , followed by, for example, the hydrolysis of thereof. The 1,4-dihydropyridine compounds [I] formed in the above-mentioned reactions can be separated from the reaction mixtures and can be purified in any conventional techniques including solvent extraction, chromatographic separation, crystallization from an appropriate solvent. Although there is no limitation in the mole ratio of the starting compounds, these compounds can be desirably used in an aroxmate equimolar amount. As is clear from the results shown in Examples below, the present compounds are eective for the prevention and treatment of hepatic disorders and also have a low toxicity. Accordingly, it is clear that the present compounds are a medicine for treatment of hepatic disease caused by various factors. The present invention will be further illustrated by, but is by no means limited to, the following examples illustrating the synthesis of the present compounds [I] as well as the pharmacological test data for the evaluation thereof. ExamPle 1 (Synthesis ExamPle) Synthesis of 3.5-dicyano-d-12-(5 ,6-dihydro-p- -dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine A 7.72 g (0.08 mol) amount of S-aminocrotononitrile having a purity of 85% was dissolved in 20 ml of acetic acid. 4.56 g (0.04 mcl) of 2-formyl-p-dioxene was dissolved in 8 ml of acetic acid. The 2-formyl-p-dioxene solution was dropwise added to the 5-aminocrotonitrile solution with stirring, while the temperature was maintained at 20 C or less. Thereafter, the temperature of the reaction mixture was raised to 600C and the reaction mixture was stirred for 5 minutes. After cooling, the reaction mixture was concentrated until dryness. The resultant residue was dissolved in ethyl acetate and the solution Was washed with an aqueous sodium bicarbonate solution and water. The solution was dried over anhydrous sodium sulfate and was evaporated to remove the solvent. The resultant residue was subjected to chromatographic purification by using a column packed with 160 g of silica gel. A mixed solvent of chloroform and ethyl acetate (3:1) (V/V) was used as an eluent. The compound thus purified was recrystallized twice from ethanol to give 2.06 g (21.2% yield) of the desired product in the form of white crystals. The analytical data of this product were as follows: m.p.: 212.0 - 213.5 C IRvKBrcm-1 : 3400 (NH), 3260 (NH), 2210 (CN) max 1660 (C=C) NMR (DMSO-d6, DSS)o: 2.01 (6H, s, 2,6-CH3), 3.70 (lH, s, 4-H), 4.01 (4H, s, O-CH2-CH2-O), 6.09 (lH, s, vinyl-H), 9.30 (1H, br, NH) Elementary analysis data (for C14H13N3 02) Calculated: C, 64.19; H, 5.39; N, 17.27(8) Found: C, 63.92; H, 5.46; N, 17.01(%) Example 2 [Synthesis Example) Synthesis of 3-acetyl-5-cyano-4-[2-(5,6-dihydro-p- dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine A 1.93 g (0.02 mol) amount of ss-aminocrotononitrile having a purity of 85%, 1.93 g (0.02 mol) of acetylacetone, and 2.28 g (0.02 mol) of 2-formyl-p-dioxene were dissolved in 10 ml of isopropanol and the resultant solution was heated under reflux for 3 hours. After cooling, the reaction mixture was evaporated until dryness. The resultant residue was subjected to chromatographic purification by using a column packed with 300 g of silica gel. A mixed solvent of chloroform and ethyl acetate (3:1) (V/V) was used as an eluent. The compound thus purified was crystallised from a mixed solvent of diethyl ether and diisopropyl ether. The crystal thus obtained was recrystallized from ethanol to give 0.82 g of the desired product in the form of pale yellow crystals. The analytical data of this product were as follows: m.p.: 172.0 - 174.0 C IRVmaxcmKBr-1 : 3280 (NH), 2200 (CN), 1680 (C=O) NMR (DMSO-d6 , DSS)6: 2.06 (3H, s, 6-CH3), 2.20 (6H, s, 2-CH3, CO-CH3) , 3.97 (5H, s, 4-H, O-CH2-CH2-O), 5.94 (1H, s, vinyl-H), 9.20 (1H, br, NH) Elementary analysis data (for C14H16N2O3) Calculated: C, 64.60; H, 6,20; N, 10.76 (%) Found: C, 64.44; H, 6.19 ; N, 10.82 (%) Example 3 (Synthesis Example) Synthesis of methyl 5-cyano-4-[2-(5,6-dihydro-pdioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3-carboxylat A 5.79 g (0.06 mol) amount of ss-aminocrotononitrile having a purity of 85%, 6.96 g (0.06 mol) of methyl acetoacetate, and 6.84 g (0.06 mol) of 2-formyl-p-dioxene were dissolved in 30 ml of isopropanol and the solution thus obtained was heated under reflux for 16 hours. After cooling, the reaction solution was evaporated until dryness. The resultant residue was subjected to chromatographic purification by using a column packed with 280 g of silica gel. A mixed solvent of chloroform and methanol (80:1) (V/V).was used as an eluent. The compound thus purified was recrystallized from ethyl acetate to give 1.04 g of the desired product in the form of pale yellow crystals. The analytical data of this product were as follows: m.p.: 185.5 - 187.00C IRvKBrmcm-1 : 3300 (NH), 2200 (CN), 1700 (C=O) 1250 (C-O) NMR (DMSO-d6 , DSS) # : 2.06 (3H, s, 6-CH3), 2.23 (3H, s, 2-CH3), 3.63 (3H, s, O-CH3), 3.87 (1H, s, 4-H), 3.96 (4H, s, O-CH2-CH2-O), 5.88 (lH, s, vinyl-H), 9.25 (lH, br, NH) Elementary analysis data (for C14H16N 204) Calculated: C, 60.86; H, 5.84; N, 10.14 (%) Found: C, 60.65; H, 5.82; N, 10.11 (%) Example 4 (Synthesis Example) Synthesis of bis(l-methyl-2-methoxyethyl) 4-[2-(5,6dihydro-p-dioxinyol)]-s,6-dimethyl-1,4-dihydropyridine3,5-dicarboxylate A 4.70 g (0.027 mol) amount of 1-methyl-2-methoxyethyl acetoacetate, 4.68 g (0.027 mol) of l-methyl-2methoxyethyl ss-amino crotonate, and 3.08 g (0.027 mol) of 2-formyl-p-dioxene were mixed and the mixture was then heated at a temperature of 1500C for 16 hours while stirring. After cooling, the reaction mixture was subjected to chromatographic purification by using a column packed with 320 g of silica gel. A mixed solvent of benzene and acetone (5:1) (V/V) was used as an eluent. The product thus purified was crystallized from a mixed solvent of diethyl ether and diisopropyl ether, and the crystal thus obtained was recrystallized from a mixed solvent of diethyl ether, diisopropyl ether, and ethanol. As a result, 0.56 g of the desired product in the form of pale yellow crystals was obtained. The analytical data of the desired product were as follows: m.p.: 120.0 - 122.0 C IRVKBRbcm-1 : 3250 (NH), 1700 (C=O), 1270 (C-O) NMR (CDC13 , TMS # : 1.25 (6H, d, 2 x CH-CH3), 2.27 (6H, s, 2,6-CH3) , 3.36 (6H, s, 2 x O-CH3), 3.45 (4H, d, 2 x CH-CH2-O), 3.91 (4H, s, O-CH2-CH2-O), 4.44 (1H, s, 4-H), 5.08 (2H, m, 2 x COO-CH), 5.85 (1H, s, vinyl-H), 6.16 (1H, br, NH) Elementary analysis data (for C21H31NO8) Calculated: C, 59.28; H, 7.34; N, 3.29 (%) Found: C, 59.26; H, 7.16; N, 3.37 (%) Example 5 [Synthesis Example) Synthesis of bis(2-cyanoethyl) 4-[2-(5,6-dihydro- p-dioxinyl)] 2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate A 2.30 g (0.02 mol) amount of 2-formyl-p-dioxene, 5.80 g (0.037 mol) of 2-cyanoethyl acetoacetate, and 3.5 ml of 28% aqueous ammonia were dissolved in 30 ml of isopropanol. The resultant solution was heated under reflux for 24 hours. After cooling, the reaction solution was concentrated and the precipitated crystal was separated by- filtration. The crystal was recrystallized from ethanol to give 2.76 g (3S.3% yield) of the desired product in the form of pale yellow crystals. The analytical data of the product were as follows: m.p.: 135.5 - 137.0 C IRVmaxKBrcm-1 : 3345 (NH), 2325 (CN), 1695 (C=O), 1200 (C-O), 1120 (C-O) NMR (CD30D, TMS) #: 2.31 (6H, s, 2,6-CH3), 2.75 (4H, t, 2 x COO-CH2-CH2-CN), 3.93 (4H, s, O-CH2-CH2-O), 4.34(4H, t, 2 x COO-CH-CH2-CN), 4.45 (lH, s, 4-H), 5.91 (lH, s, vinyl-H), 6.32 (lH, br, NH) Elementary analysis data (for C19H21N3O6) Calculated: C, 58.91; H, 5.46; N, 10.85 (z) Found: C, 58.67; H, 5.55; N, 10.58 (%) Example 6 (Synthesis Example) Synthesis of bis (methoxymethyl) 4-[2-(5,6-DIHYDRO- p-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate A 3.30 g (8.52 mmol) amount of bis(2-cyanoethyl) 4-[2-(5,6-dihydro-p-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate was dissolved in 10 ml of dimethoxyethane and then, to this solution, 50 ml of water and 17.1 ml of a 1N sodium hydroxide solution were added. The mixture was stirred at a room temperature for 1 hour and the solvent was then distilled in vacuo on a water bath at a temperature of 300C. To the resultant residue, anhydrous dimethyl formamide was added and suspended with stirring. 2.0 g (25 mmol) of chloromethyl methyl ether was added thereto and the mixture was allowed to stand with stirring overnight at a room temperature. Thereafter, the solvent was concentrated until dryness and the residue was then dissolved in ethyl acetate. The solution was washed with water and dried over anhydrous sodium sulfate. The solvent was then distilled off. The resultant residue was subjected to chromatographic purification by using a column packed with 50 g of silica gel. A mixture of n-hexane and ethyl acetate (1:1) (V/V) was used as an eluent. The resultant crystal was recrystallized from ethanol to give 0.81 g (25.7% yield) of the desired product in the form of a white crystal. The analytical data of the product were as follows: m.p.: 105.5 - 106.5 C KBr -1 IRvmax cm : 3345 (NH), 1695 (C=O), 1660 (C=C) , 1200 (C-O) , 1075 (C-O) [CDCl3, TMS) #: 2.33 (6H, s, 2,6-CH3), 3.48 (6H, s, 2 x O-CH3), 3.93 (4H, s, O-CE2-CH2-O), 4.53 (1H, s, 4-H) , 5.23, 5.39 (4H, ABq, J=6.6 Hz, 2 x O-CH2-O-CH3), 5.93 (lH, s, vinyl-H), 6.15 (lHTbr, NH) Elementary analysis data (for C17H23NO8) Calculated: C, 55.28; H, 6.28; N, 3.79 (%) Found: C, 55.44; H, 6.24; N, 3.90 (%) Example 7 (Synthesis Example) Synthesis of diisopropyl 4-[2-(5,6-dihydro-pdioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3,5 dicarboxylate To a solution of 7.21 g (0.05 mol) of isopropyl acetoacetate in 20 ml of isopropanol, gaseous ammonia was bubbled for one hour and the solution was allowed to stand overnight at a room temperature. The solvent was then distilled off. Thereafter, to the resultant residue, 7.21 g (0.05 mol) of isopropyl acetoacetate, 5.71 g (0.05 mol) of 2-formyl-p-dioxene, and 20 ml of isopropanol were added. The mixture was heated under reflux for 17 hours. After cooling, the precipitated crystal was collected by filtration and was recrystallized from isopropanol. Thus, 7.89 g (43,2% yield) of the desired product in the form of white crystals was obtained. The analytical data of the product were as follows: m.p.: 153.5 - 154.5 C IRvKBrcm-1 : 3320 (NH), 1695 (C=O), 1270 (C-O) , 1090 (C-C) NMR (CDCl3 , TMS) # : 1.26 (12H, d, 2 x CH(CH3)2), 2.27 (EH, s, 2,6-CH3), 3.90 (4H, s, O-CH2-CH2-O), 4.41 (1H, s, 4-H) 5.04 (2E, m, 2 x CH(CH3)2), 5.83 (lH, s, vinyl-H), 6.06 (1H, br, NH) Elementary analysis data (for C19H27NO6) Calculated: C, 62.45; E, 7.45; , 3.83 (%) Found: C, 62.66; H, 7.40; , 3.64 (%) Example 8 (Synthesis Example) Synthesis of diallyl 4-[2-(5,6-dihydro-p-dioxinyl)]- 2,6- imethyl-1,-aihy ropyridine-3,5-dicarboxylate A 8.00 g (0.070 mol) amount of 2-formyl-p-dioxene, 21.0 g (0.148 mol) of allyl acetoacetate, and 11.5 ml of a 28% aqueous ammonia were dissolved in 60 ml of isopropanol and the solution was heated under reflux for 24 hours. After cooling, the reactIon solution was concentrated until dryness. The resultant residue was treated with ether to crystallize the product. The crystal was collected by filtration and was recrystallized from isopropanol. As a result, 7.63 g (30.1% yield) of the desired product in the form of pale yellow crystals was obtained. The analytical data of the product were as follows: m.p.: 95.5 - 96.50C IRVKBrcm-1 : 3310 (NH), 1695 (C=O), 1260 (C-O), 1110 (C-O) NMR (CDCl3 , TMS)6: 2.30 (6H, s, 2,6-CH3), 3.93 (4H, s, O-CH2-CH2-O), 4.53 (1H, s, 4-H), 4.56 - 4.76 (4H, m, 2 x COOCH2-CH=), 5.05 - 5.50 (4H, m, 2 x CH-CH2), 5.67 - 6.30 (2H, m, 2 x CH=CH2) 5.87 (1H, s, dioxene vinyl-H), 6.05 (1H, br, NH) Elementary analysis data (for C19H23NO6) Calculated: C, 63.15; H, 6.41; N, 3.88 (g) Found: C, 63.09; H, 6.41; N, 3.77 (%) Example 9 (Synthesis Example) Synthesis of dipropargyl 4-[2-(5,6-dihydro-pdioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate A 7.00 g (0.061 mol) amount of 2-formyl-p-dioxene, 18.5 g (0.132 mol) of propargyl acetoacetate, and 10 ml of a 28% aqueous ammonia were dissolved in 60 ml of sopropanol. The mixture was heated under reflux for 24 hours. After cooling, the reaction mixture was concentrated and the precipitated crystal was collected by filtration. The crystal thus obtained was recrystallized from isopropanol to give 7.58 g (34.6% yield) of the desired product in the form of a pale yellow crystal. The analytical data of the product were as follows: m.p.: 177.0 - 179.00C IRvKBrcm-1 : 3340 (NH), 1700 (C=O), 1270 (C-O) , 1085 (C-O) NMR (CDCl3 + CD3COCD3, TMS) # : 2.30 (6H, s, 2,6-CH3), 2.56 - 2.80 (2H, m, 2 X C CH), 3.90 (4H, s, O-CH2-CH2-O), 4.43 (lH, s, 4-H), 4.63 - 4.80 (4H, m, 2 x COOCH2C=CH), 5.86 (1H, s, vinyl-H), 7.66 (1H, br, NH) Elementary analysis data (for C19H19NO6) Calculated: C, 63.85; H, 5.36; N, 3.92 (%) Found: C, 63.59; H, 5.52; N, 3.73 (%) Example 10 (Svnthesis Example) Synthesis of bis (2-methoxyethyl) 4-[2-(5,6-dihydrop-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate 4.56 g (0.04 mol) of 2-forrwl-p-dicxene, 12.80 g (0.08 mol) of 2-methoxyethyl acetoacetate, and 4.0 ml of 28% aqueous ammonia were dissolved in 40 ml cf isopropanol and the mixture was heated uncerreflux for 40 hours. After cooling, the reaction mixture was concentrated until dryness anc the rescue was dissolved n ethyl acetate. The solution was washed with a small amount of water to remove impurities | therefrom The ethyl acetate phase was dried over anhydrous sodium sulfate and the solvent was then evaporated tc give the crystal. The crystal thus obtained was washed with a small amount of ether. The crystal was recrystallized from a mixed solvent of ethyl acetate and n-hexane to give 5.02 g (31.6% yield) of the desired product in the form of whIte crystals. The analytical data of the product were as follows: m.p.: 100.0 - 101.5 C IRvKBrcm-1 : 3280 (NH), 1680 (C=O), 260 (C-O), 1100 (C-O) NMR (CDCl3, TMS) # : 2.30 (6H, s, 2,6-CH3), 3.42 (6H, s, 2 x OCH3), 3.67 (4H, t, 2 x COOCH2-CH2-O), 3.93 (4H, s, OL-CH2-CH2-O), 4.30 (4H, m, 2 X COOCH2-CH2-O), 4.50 (1H, s, 4-H), 5.95 (lH, s, vinyl-H), 6.13 (lH, br, NH) Elementary analysis data (for C19H27NO8) Calculated: C, 57.42; H, 6.85; N, 3.52 (%) Found: C, 57.58; H, 6.89; N, 3.42 (%) Example 11 (Svnthesis Example) Synthesis of ispropyl methyl 4-[2-(5,6-dihydrop-dioximyl)]-2,6-dimethyl-1,4-dihydropyridine-3,5 dicarboxylate a) A 8.64 g (0.06 mol) amount of isopropyl acetoacetate and 6.84 g (0.06 mol) of 2-formyl-p-dioxene were dissolved in 30 ml of isopropanol and 5 drops of piperidine was added thereto. The mixture was allowed to stand for one week at a room temperature while stirring. Then, the solvent was removed by evaporation and the residue was subjected to chromatographic purification by using a column packed with 450 g of silica gel. A mixed solvent of n-hexane and ethyl acetate (1:1) (V/V) was used as an eluent. As a result, 5.89 g (40.8% yield) of isopropyl 1-[2-(5,6-dihydro-p- dioxinyl)] -3 -oxo- l-butene-2-carboxylate was obtained. b) A 3.79 g (0.016 mol) amount of isopropyl 1 [2-(5,6-dihydro-p-dioxinyl)]-3-cxo-1-butene-2-carboxylate and 1.82 g (0.016 mol) of methyl ss-aminocrotonate were dissolved in 10 ml of isopropanol and the mixture was heated under reflux for 5 hours. After cooling, the solvent was removed by evaporation. The oily residue thus obtained was crystallized from a mixed solvent of diethyl ether and n-hexane. The crystal was collected by filtration and was recrystallized from diisopropyl ether. Thus, 1.14 g (21.1% yield) of the desired product in the form of a white crystal was obtained. The analytical data of the product were as follows: m.p.: 135.5 - 137.50C IRMmBaxcm 1 3320 (NH), 1700 (C=O), 1275 (C-O) , 1105 (C-O) NMR (CDC13 , TMS) # : 1.27 (6H, d, CH(CH3)2), 2.29 (6H, s, 2,6-CH3), 3.71 (3H, s, OCH3), 3.91 (H, s, O-CH2-CH2-O), 4.43 (1HT-s, 4-H), 5.06 (lH, m, CW(CH3)2) 5.83 (1H, s, vinyl-H), 6.13 (1H, br, NH) Elementary analysis data (for C17H23NO6) Calculated: C, 60.52; H, 6.87; N, 4.15 (%) Found: C, 60.34; H, 6.74; N, 4.00 (%) Example 12 (Synthesis Example) Synthesis of 3,5-diacetyl-4-[2- (5,6-dihydrc-p- dioxinyl)]-2,6-dimethyl-1,4-dihydropyridins A 2.85 g (0.025 mol) amount of 2-formyl-p-dioxene, 2.50 g (0.025 mol) of acetyl acetone, and 2.48 g (0.025 mol) of 4-amino-3-pentene-2-one were mixed and heated at a temperature of 110 C for 24 hours while stirring. After cooling, the reaction mixture was subjected to chromatographic purification by using a column packed with 15 g of silica gel. A mixed solvent of chloroform and ethyl acetate (5:1) (V/V) was used as an eluent. The crystal thus obtained was recrystallized from isopropanol to give 0.97 g (14.0% yield) of the desired product in the form of a pale yellow crystal. The analytical data of the product were as follows: m.p.: 186.0 - 187.00C IRVKBrcm-1 : 3260 (NH), 1660 (C=O), 1230 (C-O) NMR (CDCl3, TMS) # : 2.30 (6H, s, 2,6-CH3), 2.34 (6H, s, 2 x COCH3), 3.93 (4H, s, O-CH2-CH2-O), 4.50 (1H, s, 4-H), 5.75 (lH, s, vinyl-H), 7.35 (1H, br, NH) Elementary analysis data (for C 15H19NO4) Calculated: C, 64.97; H, 6.91; N, 5.05 (%) Found: C, 65.09; H, 6.80; N, 4.90 (%) Example 13 (Synthesis Example) Synthesis of 3,5-diacetyl-4-[2-(5,6-dihydro-pdioxinyl)]-2,6-dimethyl-1,4-dihydropyridine A 20.0 g (0.175 mol) amount or 2-formyl-p-dioxene, 18.5 g (0.185 mol) of acetyl acetone, and 18.1 g (0.183 mol) of 4-amino-3-penten-2-one were dissolved in 100 ml of pyridine and the mixture was heated under reflux for 48 hours. After cooling, the reaction mixture was concentrated until dryness and the residue was crystallized by treating it with diethyl ether. The crystal was collected by filtration and was then recrystallized from isopropanol. Thus, 18.0 g (37.0% yield) of the desired product in the form of a pale yellow crystal was obtained. Example 14 (Synthesis Example) Synthesis of methyl 5-acetyl-4- [2-(5,6-dihydro-p- dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate a) A 11.6 g (0.10 mcl) amount of methyl acetoacetate and 11.4 g (0.10 mol) of 2-formyl-p-dioxene were dissolved in 50 ml of isopropanol and 10 drops of piperidine were added thereto. The mixture was allowed to stand for 5 days at a temperature of 400C to 600C while stirring. Then, the solvent was removed from the reaction mixture by evaporation. The residue was subjected to chromatographic purification by using a column packed with 680 g of silica gel. A mixed solvent of benzene and ethyl acetate (3:1) (V/V) was used as an eluent. Thus, 4.02 g (19.0% yield) of oily methyl 1-[2-(5,6-dihydro-p-dioxinyl)]-3-oxo-1-butene-2-carboxylate was obtained. b) A 4.02 g (0.019 mol) amount of methyl 1-[25,6-dihydro-p-dioxinyl)]-3-oxo-1-butene-2-carboxylate and 1.88 g (0.019 mol) of 4-amino-3-penten-2-one were dissolved in 15 ml of isopropanol and the mixture was heated under reflux for 10 hours. After cooling, the solvent was removed by evaporation and the oily residue was crystallized by treating it with diethyl ether. The crystal thus obtained was collected by filtration. The crystal was recrystallized from ethanol to give 2.16 g (38.8% yield) of the desired product in the form of a pale yellow crystal. The analytical data of the product were as follows: m.p.: 159.5 - 160.5 C IRK -1 max : 3320 (NH) , 1710 (C=O) , 1670 (C=O) , 1220 (C-O), 1120 (C-O) NMR (CDC13 , TMS) # : 2.27 (3H, s, COCH3), 2.30 (6H, s, 2,6-CH3) , 3.73 (3H, s, O-CH3) 3.91 (4H, s, O-CH2-CH2-O), 4.46 (1H, s, 4-H), 5.78 (1H, s, vlnyl-H), 6.47 (lH, br, NH) Elementary analysis data (for C15H19N05) Calculated: C, 61.42; H, 6.53; N, 4.78 (%) Found: C, 61.24; H, 6.48; N, 4.66 (g) Example 15 (Svnthesis Example) Synthesis of 2-methoxyethyl 5-acetyl-4-[2-(5,6- dihydro-p-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine3-carboxylate. A 2.96 g (0.03 mol) amount of t-amino-3-penten- 2-one, 4.79 g (0.03 mol) of 2-methoxyethyl acetoacetate, and 3.39 g (0.03 mol) of 2-formyl-p-dioxene were dissolved in 15 ml of isopropanol and the mixture was heated under reflux for 16 hours. After cooling, the reaction mixture was concentrated until dryness and the residue was subjected to chromatograph purification by using a column packed with 500 g of silica gel. A mixed solvent of benzene and acetone (3:1) (V/V) was used as an eluent. The purified product was crystallized from diethyl ether. The crystal was recrystallized frcm a mixed solvent of diisopropyl ether and diethyl ether and was further recrystallized from diethyl ether. Thus, 0.55 g of the desired pale yellow product was obtained. The analytical data of the product were as ollows: m.p.: 106.0 - 110.00C IRvmaxKBrcm-1 : 3310 (NH), 1700 (C-O), 1670 (C=O), 1220 (C-O) NMR (CDC13 , TMS) # : 2.30 (9H, s, 2,6-CH3 CO-CH3), 3.40 (3H, s, OCH3), 3.63 (2H, t, COO-CH2-CH2-O), 3.93 (4H, s, O-CH2-CH2-O), 4.33 (2H, m, COO-CH2-CH2-O), 4.47 (1H, s, 4-H), 5.85 (1H, s, vinyl-H), 6.15 (1H, br, NH) Elementary analysis data (for C17H23NO6) Calculated: C, 60.52; H, 6.87; N, 4.15 (%) Found: C, 60.30 ; H, 6.77; N, 3.98 (%) Example 16 (Svnthesis Example) Synthesis of 3,5-diacetyl-4-[2-(5,6-dihydro-pdioxinyl)]-1-methoxymethyl-2,6-dimethyl-1,4-dihydro pyridine To a suspension of 25 ml cf dimethoxyethane and 0.40 g (0.01 mol) of sodium hydride (60% dispersion in mineral oil), 1.0 g (0.0036 mol) of 3,5-diacetyl-4 [2-(5,6-dihydro-p-dioxinyl)]-2,6-dimethyl-1,4-dihydropyridine obtained in the same manner as described in Example 12 was added. The mixture was stirred under ice cooling for 30 minutes. Then, 0.81 g (0.01 mol) of chloromethyl methyl ether was dropwise added thereto. The mixture was further stirred at a room temperature for 2 hours. Then, the dimethoxyethane was distilled off in vacua. The resultant crystal was washed with diethyl ether and was recrystallized from a mixed solvent of n-hexane and dichloromethane. Thus, 0.50 g (3.14 yield) o-f the desired product in the form of a yellow crystal was obtained. The analytical data of the product were as follows: m.p.: 126.0 - 127.50C IRvmaxcm-1 KBr: 1660 (C=O), 1645 (C-C), 1220 (C-O) NMR (CDC13 , TMS) # : 2.35 (6H, s, 2,6-CH3), 2.37 (6H, s, 2 x COCH3) , 3.33 (3H, s, CH2-O-CH3), 3.90 (4H, s, O-CH2-CH2-O), 4.43 (1H, s, 4-H), 4.73 (2H, s, N-CH2-O), 5.67 (1H, s, vinyl-H) Elementary analysis data (for C17H23NO5) Calculated: C, 63.5a; H, 7.21; N, 4.36 (%) Found: C, 63.61; H, 7.23; N, 4.53 (%) Example 17 (Synthesis Example) Synthesis of bis (methoxymethyl) 4-[2-(5,6-dihydro- p-dioxinyl)]-1-methoxymethyl-2,6-aimethyl-1,-dihydro- pyridine-3, 5-dicarboxylate A 2.60 g (7.04 mmol) amount of bis(methoxymethyl) 4-[2-(5,6-dihydro-p-dioxinyl)]-2,6-dimethyl-1,4-dihydro pyridine-3,5-dicarboxylate obtained in the same manner as in Example 6 was dissolved in 30 ml of dimethcxyethane. To this solution, 0.48 g (12 mmcl) of sodium hydride (60% distension in mineral oil) was added under ice cooling while stirring and was further stirred at a room temperature for 20 minutes. The resultant solution was again stirred under ice cooling and a solution of 1.00 g (12.4 mmol) of chloromethyl methyl ether dissolved in 10 ml of dimethoxyethane was added thereto and was further stirred for 30 minutes under ice cooling. Then, the dimethoxyethane was distilled off in vacuo and ethyl acetate was added to the residue. The mixture was washed with water and dried over anhydrous sodium sulfate and the solvent was then removed by evaporation. The residue was subjected to chromatographic purification by using a column packed with 100 g of silica gel. A mixed solvent of n-hexane and ethyl acetate (1:1) (V/V) was used as an eluent. The crystal thus obtained was recrystallized frcm diethyl ether to give 1.19 g (40.98 yield) of the desired product in the form of a white crystal. The analytical data o the product were as follows: m.p.: 78.5 - 80.0 C IRvmaxcm-1KBr : 1705 (C=O), 1680 (C=C), 1140 (C-O) NMR (CDC13 , TMS) #: 2.49 (6H, s, 2,6-CH3), 3.34 (3H, s, N-CH2-O-CH3), 3.48 (6H, s, 2 x COO-CH2-O-CH3J, 3.90 (4H, s, O-CH2-CH2-O) , .63 (1H, s, 4-H), 4.74 (2H, s, N-CH2-O), 5.25, 5.38 (4H, ABq, J=6.04 Hz, 2 X COO-CH2-O-CH3), 5.83 (1H, s, vinyl-H) Elementary analysis data (for C19H27NO9) Calculated: C, 55.20; H, 6.58; N, 3.39 (%) Found: C, 55.28; H, 6.57; N, 3.48 (%) Example 18 (Synthesis Example) a) Synthesis of 2-formyl-3,5-dimethyl-p-dioxene A 35.9 g (0.234 mol) amount of phosphorus oxychloride was dropwise added to 62 ml of dimethyl formamide under ice cooling and, then 25.4 g (0.223 mol) of 2,6-dimethyl-p-dioxene was dropwise added thereto at a temperature of not more than 10"C. The mixture was stirred at a temperature of 300C for one hour. The resultant reaction mixture was poured into 120 g of ice water and was neutralized with a suspension of 110 g of sodium bicarbonate in 100 ml of water. The mixture was extracted with chloroform and the extract was dried over anhydrous sodium sulfate. The chloroform was then distilled off to give 23.5 g (74.2% yield) of the desired oily product having the following NMR data. NMR (CDC13 , TMS)Ï: 1.33 (3H, d, dioxene-5 CH3), 2.20 (3H, s, dioxene-3-CH), 3.40 - 4.67 (3H, m, EMI25.1 9.53 (lH, s, CHO) b) Synthesis of 3,5-diacetyl-2,6-dimethyl-4- 2 (3 ,5-dimethyl-5 ,6-dihydro-p-dioxinyl) -1,4-dihydro pyridine A 2.84 g (0.02 mol) amount of 2-formyl-3,5dimethyl-p-dioxene, 2.00 g (0.02 mol) of acetylacetone, and 3.0 g (0.03 mol) of 4-amino-3-penten-2-one were dissolved in 20 ml of isopropanol. The solution thus obtained was reacted a sealed tube at a temperature of 165 C for 72 hours. After cooling, the reaction mixture was concentrated until dryness and the residue was dissolved in ethyl acetate. The resultant solution was washed with water and was then dried over anhydrous sodium sulfate. The solvent was removed by evaporation and the crystalline product was obtained. The resultant crystal was washed with cold diethyl ether. The product was recrystallized from ethyl acetate to give 0.74 g of the desired product in the form of a pale yellow crystal. The analytical data of the product were as follows: m.p.: 177.5 - 182.50C IR9maxCm 1 3300 (NH) , 1660 (C=O), 1590 (C=C), 1220 (C-O) NMR (CDCL3 , TMS) # : 1.13 (3E, d, dioxene-5 CH3), 1.90 (3H, s, dioxene-3-CH3), 2.27 (6H, s, 2 x COCH3), 2.30 (6H, s, 2,6-CH3), 3.17 - 4.13 (3H, m, EMI26.1 4.63 (lH, s, 4-H) , 6.50 (lH, br, NH) Elementary analysis data (for C17H23NO4) Calculated: C, 66.86; H, 7.59; N, 4.59 (%) Found: C, 66.92; H, 7.44; N, 4.70 (%) Example 19 (Synthesis Example) Synthesis of dimethyl 2,6-dimethyl-4-[2-(3,5dimethyl-5,6-dihydro-p-dioxinyl)]-1,4-dihydropyridine3,5-dicarboxylate A 2.84 g (0.02 mol) amount of 2-formyl-3,5- dimethyl-p-dioxene, 4.64 g (0.04 mol) of methyl acetoacetate, and 2.30 g (0.02 mol) of methyl ss-aminocrotonate were mixec anc the mixture was stirred at a temperature of 120 C for 6 hours and at a temper- ature of 140 C for further 2 hcurs. After cooling, the react Ion mixture was subjected to chromatographic purification by using a column packed with 200 g of silica gel. A mixed solvent of benzee and ethyl acetate (4:1) (V/V) was used as an eluent. The product was crystallized from diethyl ether to give 1.28 g of the desired product in the form of a pale yellow crystal. The analytical data of the product were as follows: m.p.: 153.5 - 157.5 C IRvmaxKBr-1 : 3320 (NH), 1690 (C=O), 1640 (C=C), 1210 (C-O) NMR (CDCl3 , TMS) # : 1.17 (3H, d, dioxene-5 CH3), 1.90 (3H, s, dioxene-3-CH3), 2.23 (6H, s, 2,6-CH3), 3.67 (6H, s, 2 x COOCH3), 3.10 - .30 (3H, m, EMI26.2 4.67 (1H, s, 4-H), 6.00 (1H, br, NH) Elementary analysis data (for C17H 23NO6) Calculated: C, 60.52; H, 6.87; N, 4.15 (%) Found: C, 60.24; H, 6.78; N, 4.33 (%) Example 20 (SynthesIs ExamDle) Synthesis of bis (2-cyanoethyl) 2,6-dimethyl-4 [2-(3,5-dimethyl-5,6-dihydro-p-dioxinyl)]-1,4dihydropyridine-3,5-dicarboxylate A 1.42 g (10.0 mmol) amount of 2-formyl-3,5dimethyl-p-dioxene, 1.60 g (10.3 mmol) of 2-cyanoethyl acetoacetate, and 1.60 g (10.4 mmol) of 2-cyanoethyl S-aminocrotonate were stirred at a temperature of 100 C for 16 hours. After cooling, the reaction mixture was subjected to chromatographic purification by using a column packed with 200 g of silica gel. A mixed solvent of n-hexane and'methyl acetate (1:1) (V/V) was used as an eluent. Thus, 2.02 g (48.6% yield) of the desired oily product having the following analytical data was obtained. IRvmaxcm-1 KBr: 3450 (NH), 2325 (CN), 1725 (C=O), 1120 (C-O) NMR (CDCl3 , TMS) # : 1.13 (3H, d, dioxene-5-CH3), 1.93 (3H, s, dioxene-3-CH3), 2.30 (6H, s, 2,6-CH3), 2.73 (H, t, 2 x COO-CH2-CH2-CN), 3.20 - 4.10 (3H, m, EMI27.1 4.30 (4H, t, 2 x COO-CH2-CH2-CN), 4.61 (1H, s, 4-H), 6.33 (1H, br, NH) Example 21 (Synthesis Example) a) Synthesis of 2,6-dimethyl-4-[2-(3,5-dimethyl- 5,6-dihydro-p-dioxinyl)]-1,4-dihydropyridine-3,56dicarboxylic acid A 2.02 g (4.86 mmol) amount of bis (2-cyanoethyl) 2,6-dimethyl-4-[2-(3,5-dimethyl-5,6 dihydro-p-dioxinyl)]-l,a-dihydropyridine-3,5- dicarboxylate was dissolved in 10 ml of dimethoxyethane. To this solution, 25 ml of water and 9.6 ml of a 1N aqueous sodium hydroxide solution were added. The mixture was stirred at a room temperature for 5 hours. The reaction mixture was washed five times with dichloromethane and a IN aqueous hydrochloric acid was then added thereto. The precipitated crystal was collected by filtration. The crystal was washed with water and dried. Thus, 0.51 g (33.9% yield) of the desired product having the following analytical data was obtained. IRvmaxcm-1KBr : 3350 (NH), 1675 (C=O), 1210 (C-O) b) Synthesis of bis (methoxymethyl) 2,6-dimethyl4-[2-(3,5-dimethyl-5,6-dihydro-p-dioxinyl)]-1,4dihydropyridine-3,5-dicarboxylate A 1.16 g (3.75 mmol) amount of 2,6-dimethyl- 4-[2-(3,5-dimethyl-5,6-dihydro-p-dioxinyl)]-1,4dihydropyridine-3,5-dicarboxylic acid was suspended in a mixed solvent of 15 ml of dimethoxyethane and 3 ml of dimethylformamide. To the suspension, 0.90 g (8.91 mmol) of triethylamine and 0.70 g (8.70 mmol) of chloro- methyl methyl ether were dropwise added and stirred for 2 hours under ice cooling 2. Then, the solvent was distilled off in vacuo on a water bath at a temperature of 30 C. The resultant residue was dissolved in ethyl acetate and was then washed with ice water. The solution was cried over anhydrcus sodium sulfate and the solvent was removed by evaporation. The resultant residue was subjected to chromatographic purification by using a column packed with 70 a of silica gel. A mixed solvent of n-hexane and ethyl acetate (1:1) (V/V) was used as an eluent. The resultant crystal was recrystallized from diethyl ether to give 0.43 g (28.8% yield) of the desired product in the form of white crystals. The analytical data of the product ere as follows: m.p.: 79, 5 - 81.5 C IRvmaxcm-1KBr : 3350 (NH), 1700 (C=O), 1650 (C=C) , 1200 (C-O) NMR (CDCl3 , TMS)6: 1.13 (3H, d, dioxene-5-CH3), 1.95 (3H, s, dioxene-3-CH3) , 2.30 (6H, s, 2,6-CH3), 3.17 - 4.13 (3H, m, EMI29.1 3.43 (6H, s, 2 x O-CH3), 4.70 (1H, s, 4-H), 5.27 (4H, s, 2 x COO-CH2-O), 5.90 (lH, br, NH) Example 22 (Synthesis Example) a) Synthesis of 2-formyl-3-methyl-p-dioxene The reaction, in the same manner as in Example 18(a), was carried out by using 50 ml of dimethyl formamide, 16.5 ml (1.80 mol) of phosphorus oxychlorlde, and 16.5 g (0.165 mol) of 2-methyl-p-dicxene. As a result, 18.2 g (86.2% yield) of the oily desired product having the following NMR data was obtained. NMR (CDCl3 , TMS)6: 2.20 (3H, s, dioxene-3-CH3), 4.00 - 4.50 (4H, m, O-CH2-CH-O), 9.47 (1H, s, CHO) b) Synthesis of 3,5-aiacetyl-2,6-dimethyl-fl-[2- (3-methyl-5,6-dihydro-p-dioxinyl)]-1,4-dihydropyridine A 12.8 g (0.1 mol) amount of 2-formyl-3methyl-p-dioxene, 10.0 g (0.1 mol) of acetyl acetone, and 10.0 g (0.1 mol) of 4-amino-3-penten-2-one were dissolved in 30 ml of isopropanol. The mixture was heated in a sealed tube at a temperature of 1600C for 15 hours. After cooling, the reaction mixture was concentrated until dryness to give a crystal. The crystal thus obtained was washed with diethyl ether and was then recrystallized from ethanol. Thus, 2.62 g of the desired product in the form of pale yellow crystals was obtained. The analytical data of the product were as follows: m.p.: 201.5 - 203.00C IRvmaxcm-1KBr : 3320 (NH), 1660 (C-O), 1590 (C=C) , 1220 (C-O) NMR (DMSO-d6, DSS) # : 1.83 (3H, s, dioxene-3-CH3), 2.20 (12E, s, 2,6 CH3 , 2 x COCH3), 3.80 (4H, s, O-CH2-CH2-O), 4.53 (lH, s, 4-H), 8.53 (1H, br, NH) Example 23 (Synthesis Example) a) Synthesis of 2-formyl-3-methcxymethyl-p- aloxene A 28.80 g (0.25 mol) amount of 2-formyl-p cioxene was dissolved in 250 ml of water. To this solution, 2.50 g (0.066 mol) of sodium borohydride was added with stirring under ice cooling and the mixture was stirred at a room temperature for ten minutes. After stirring, the solution was saturated with sodium chloride and was then extracted with chloroform. The chloroform phase was dried over anhydrous sodium sulfate and the solvent was, then, removed by evaporation. Thus, 29.16 g (99.5% yield) of the desired oily 2hydroxymethyl-p-dioxene was obtained. The analytical data of the product were as follows: b.p.: 660C (0.1 mmEg)- NMR (CDCl3 , TMS)6: 2.30 (1E, s, OH), 3.93 (2H, s, CH2-OH), 4.05 (4H, m, O-CH2-CH2-O), 6.06 (1H, s, vinyl-H) Thereafter, 10.0 g(0.25 mol) of sodium hydride (60% dispersion in mineral oil) was mixed with 250 ml of dimethoxyethane and 29.16 g (0.25 mol) of 2-hydroxymethyl-p-dioxene was dropwise added to the mixture at a room temperature while stirring. Then, 38.3 g (0.25 mol) of methyl iodide (purity: 93%) was dropwise added thereto under ice cooling while stirring. The mixture was heated at a temperature of 40 C for 16 hours while stirring. Then, the dimethoxyethane was concentrated. The concentrate was poured into water and extracted with chloroform. The chloroform phase obtained above was dried over anhydrous sodium sulfate and the solvent was removed by evaporation. The residue was dissolved in acetonitrile and the solution was washed with n-hexane. The solvent was removed by evaporation to give 28.70 g (87.8% yield) of the desired oily 2-methoxymethyl-pdioxene. The analytical data of the product were as follows: b.p.: 62.50C (9 mmHg) NMR (CDC13 , TMS)o: 3.31 (3H, s, O-CH3), 3.76 (2H, s, CH2-O-CH3) , 4.07 (4H, m1 O-CH2-CH2-O), 6.08 (1H, s, vinyl-H) A 37.19 g (0.24 mol) amount of phosphorus oxychloride was dropwise added to 70 ml of dimethylformamide with stirring under ice cooling and 28.70 g (0.22 mol) of 2-methoxymethyl-p- -dioxene was then dropwise added to the mixture. The mixture was stirred for 1 hour under ice cooling, 1 hour at a room temperature, and 1 hour at a temperature of 500C. The reaction mixture was cocled and poured into water. The mixture was neutralized with sodium bicarbonate and was then extracted with chloroform. The chloroform phase was dried over anhydrous sodium sulfate and was concentrated until dryness. The residue was distilled in. vacuo to give 15.67 g (44.98 yield) of the desired oily product. The analytical data of the product were as follows: b.p.: 880C (0.3 mmHg) NMR (CDC13 , TMS)6: 3.42 (3H, s, O-CH3), 4.22 (4H, m, O-CH2-CH2-O) , 4.33 (2H, s, CH2-O-CH3), 9.61 (1H, s, CHO) b) Synthesis of 3,5-diacetyl-4- 2-(3-methoxymethvl-5,6-dihydro-p-dioxinyl) -2,6-imethyl-1,4- dihydropyridine A 3.55 g (0.034 mol) amount of 4-amino-3 pentene-2-one, 3.38 g (0.034 mo') of acetylacetone, and 3.56 g (0.023 mol) of 2-formyl-3-methoxymethyl-pdioxene were dissolved in 10 ml of isopropanol and the mixture was heated at a temperature of 1200C for 16 hours in a sealed tube. After cooling, the reaction mixture was concentrated until dryness. The residue was subjected to chromatographic purification by using a column packed with 300 g of silica gel. Ethyl acetate was usec as an eluent. The crystaline product was recrystallized from a mixed solvent of ethanol and diisopropyl ether to give 0.70 g of the desired product in the form of pale yellow crystals. The analytical data of the product were as follows: m.p.: 159.C - 160.0 C IRvmaxcm-1KBr : 3370 (NH), 1665 (C=O), 1210 (C-O) NMR (CDC13 , TMS) # : 2.27 (5H, s, 2,6 CH3), 2.32 (6H, s, 2 X COCH3), 3.35 (3H, s, O-CH3), 3.89 (H, s, OCH2- CH2-O), 4.17 (2H, s, CH2-O-CH3), 4.80 (1H, s, 4-H), 6.74 (1H, br, NH) Elementary analysis data (for C17H23NO5) Calculated: C, 63.54; H, 7.21; N, 4.36 (%) Found: C, 63.26; H, 7.30; N, 4.58 (%) Example 24 (Svnthesis Example) Synthesis of 3,5-diacetyl-4-[5-(3,4-dihydro-2Hpyranyl)]-2,6-dimethyl-1,4-dihydropyridine A 8.89 g (79.3 mmol) amount of 5-formyl-3,4- dihydro-2H-pyrane, 8.35 g (83.4 mmol) of acetylacetone, and 8.20 g (82.7 mmol) of 4-amino-3-penten-2-one were dissolved in 100 ml of pyridine and the resultant solution was heated under reflux for one week. After cooling, the reaction mixture was concentrated until dryness. The residue was subjected to chrcmtaoographic purification by using a column packed with 500 g of silica gel. A mixed solvent of n-hexane and ethyl acetate (1:1) (V/V) was used as an eluent. The resultant crystal was recrystallized from ethanol. Thus, 0.89 g of the desire product in the form of pale yellow crystals was obtain3ed. The analytical data of the product were as follows: m.p.: 192.0 - 192.50C IRvmaxcm-1 KBr: 3280 (NH), 1640 (C=O), 1220 (C-O) max NMR (CDCl3, TMS) #: 1.70 - 1.90 (4H, m, dihydropyrane-3,4-CH2), 2.27 (5H, s, 2,6-CH3), 2.30 (6H, s, 2 x COCH3) , 3.,0 3.95 (2H, m, dihydropyrane-2-CH2)1 4.35 (lH, s, 4-H) , 6.34 (lH, s, vinyl-H) , 6.57 (lH, br, NH) Elementary analysis data (for C16H21NO3) Calculated: C, 69.79; H, 7.69; N, 5.09 (%) Found: C, 69.77; H, 7.62; N, 5.20 (%) Example 25 (Svnthesis Example) a) Synthesis of 2-formyl-l,k-cithiene A 22.2 g (0.1t mol) amount of phosphorus oxychloride was dropwise added to 31.0 g (0.42 mcl) of dimethylformamide with stirring under ice cooling, while the temperature of the reaction mixture was maintained at a temperature of 0 C to 50C. 16.6 g (0.14 mol) of 1,4-dithiene was then dropwise added to the resultant reaction mixture, while the temperature of the reaction mixture was maintained at not more than 10 C. After the temperature of the reaction mixture was gradually raised to a room temperature, the reaction mixture was stirred for 30 minutes on a water bath at a temperature of 600C to complete the reaction. Then, the reaction mixture was poured into ice water and was then hydrolyzed with sodium bicarbonate. The aqueous mixture was saturated with sodium chloride and was extracted with chloroform. The chloroform phase was dried over magnesium sulfate. The solvent was then removed by evaporation. The oily substance thus obtained was distilled in vacuo to give 10.8 a (52.6% yield) of the desired oily product. The analytical data of the product were as follows: b.p. : 123.5 C (0.7 mmHg) IRvmaxcm-1KBr : 1650 (C=O), 1150 (C-O) (CD3OD, TMS) #: 3.25 (4X, m, S-CH2-CH2-S), 7.47 (1H, s, vinyl-H), 9.20 (1H, s, CHO) b) Synthesis of 3,5-diacetyl-4-[2-(5,6-dihydro1,4-dithiinyl)]-2,6-dimethyl-1,4-dihydropyridine A 2.97 g (20.3 mmol) amount of 2-formyl-1,4dithiene, 2.25 5 (22.5 mmol) of acetylacetone, ana 2.20 g (22.2 mmol) of 4-amlno-3-pentene-2-one were dissolved in 40 ml of pyridine and the mixture was heated under reflux for 48 hours. After cooling, the reaction mixture was concentrated until dryness. The crystalline residue was recrystallized from ethyl acetate to give 0.96 g of the desired product in the form of yellow crystals. The analytical data of the product were as follows: m.p.: 206.5 - 208.0aC IRvmaxcm-1 KBr: 3280 (NH), 1660 (c=o), 1640 max (C=C), 1220 (C-O) NMR (CDCl3 , TMS) # : 2.33 (6H, s, 2,6 CH3), 2.36 (6H, s, 2 x COCH3), 3.06 (H, s, S-CH2-CH2-S), .70 (1H, s, 4-H), 5.93 (1H, s, vinyl-H), 6.97 (lH, br, NH) Elementary analysis data (for C15H19NO2S2) Calculated: C, 58.22; H, 6.19; N, 4.53; S, 20.72 (%) Found: C, 58.19; H, 6.19; N, 4.67; S, 20.50 (%) Example 26 (Evaluation Example) Effect of the compounds according to the present invention on liver disorder induced by carbon tetrachloride The effects of the sample compounds to be tested on hepatic disorder were evaluated by determining the levels of GOT, GPT, A1P, and bilirubin, which are known as an indicator of hepatic disorder, in serum, after administering carbon tetrachloride and the sample compounds to SLC-Wistar male rats (9 weeks old and body weight of 210 to 250 g in Tables 1, 3, and 4, and 10 weeks old and body weight of 230 to 260 g in Table 2) as follows. Five rats were used in each test group. The sample compound (i.e., each compound listed below) was suspended at a concentration of 40 mg/ml in a 0.1% aqueous solution of Tween-80 (i.e., nonionic surfactant available from Atlas Powder Co., Ltd.). The resultant suspension was orally administered at a dose of 200 mg/kg each at 25 hours and 1 hour before the administration of carbon tetrachloride, except for the control group. For the control group to which only carbon tetrachloride was administered in the evaluation test, a 0.1% aqueous Tween-80 was orally administered at a dose of 5 ml/kg in the same manner. Carbon tetrachloride was intraperiotoneally administered as a 10% olive oil solution at a dose of 5 ml/kg (0.5 ml/kg in terms of CCl4) one hour after the final administration of the sample compound. For the control (normal) group, olive oil was intraperitoneally administered in the same manner at a dose of 5 ml/kg. Blood samples were collected from the carotid artery under pentobarbital anesthesia, 24 hours after the administration of carbon tetrachloride. The rats were fasted for 18 to 22 hours before collecting the blood samples. The determination of GOT and GPT in serum was carried out according to a UV method, the determination of A1P was carried cut according to Bessy-Lowry method, and the determination of bilirubin was carried out accoding to a diazo method. The results are shown in Tables 1 to 4. The sample compounds A to Q are as follows: Example No. Sample Compound 1 A 2 B 3 C 4 D 6 F 7 G 8 H 9 I 10 J 11 K 12 L 14 M 15 N 18(b) o 24 P 25(b) Q Table 1 GOT GPT AlP Bilirubin (K.U.) (K.U.) (K-AU.) (mg/dl) Conrol (normal) 76 # 1 31 # 2 23.6 # 0.4 0.10 # 0.00 CCl4 17327 # 2336 10496 # 1221 35.5 # 2.5 0.62 # 0.30 A + CCl4 3874 # 792 2380 # 472 31.4 # 0.9 0.24 # 0.02 B + CCl4 1604 # 569 1023 # 368 34.1 # 3.4 0.20 # 0.00 D + CCl4 2574 # 518 2050 # 419 31.0 # 1.5 0.20 # 0.00 Table 2 GOT GPT AlP Bilirubin (K.U.) (K.U.) (K-AU.) (mg/dl) Control (normal) 89 # 12 41 # 3 22.7 # 0.6 0.10 # 0.00 CCl4 20701 # 2821 11034 # 1354 32.3 # 2.8 0.40 # 0.09 C + CCl4 1447 # 313 912 # 198 31.7 # 3.2 0.20 # 0.00 <RTI ID=39.1> Table 3 GOT GPT AlP Bilirubin (K.U.) (K.U.) (K-AU.) (mg/dl) Control (normal) 81 # 3 30 # 2 27.0 # 0.5 0.22 # 0.04 CCl4 13189 # 2205 9188 # 1815 34.4 # 2.6 0.38 # 0.06 F + CCl4 432 # 107 274 # 99 26.4 # 1.0 0.22 # 0.05 O + CCl4 565 # 98 410 # 64 37.2 # 1.6 0.26 # 0.02 P + CCl4 899 # 252 616 # 193 35.1 # 1.4 0.32 # 0.02 Q + CCl4 2583 # 540 1891 # 357 29.8 # 1.3 0.26 # 0.02 Table 4 GOT GPT AlP Bilirubin (K.U.) (K.U.) (K-AU.) (mg/dl) Control (normal) 76 # 4 31 # 3 24.4 # 0.7 0.10 # 0.00 CCl4 17704 # 4140 10523 # 2313 35.0 # 2.0 0.38 # 0.04 G + CCl4 3482 # 707 2994 # 638 31.5 # 1.2 0.22 # 0.02 H + CCl4 1920 # 881 1453 # 699 29.5 # 2.4 0.22 # 0.04 I + CCl4 2925 # 380 2110 # 228 27.6 # 1.8 0.22 # 0.02 J + CCl4 607 # 211 626 # 179 27.4 # 2.6 0.18 # 0.03 K + CCl4 2290 # 619 1657 # 436 29.6 # 0.8 0.24 # 0.02 L + CCl4 429 # 113 285 # 96 34.2 # 1.5 0.22 # 0.02 M + CCl4 807 # 176 428 # 88 29.1 # 1.1 0.20 # 0.00 N + CCl4 3430 # 922 2860 # 858 28.5 # 1.7 0.18 # 0.02 Example 27 (Evaluation Example) Effect of the compounds according to the present invention on liver disorder induced by carbon tetrachloride The evaluation tests of Example 26 were repeated except that SLC-Wistar male rats (8 weeks old and body weight of 170 to 210 g) were used. The results are shown in Tables 5 and 6. The sample compounds are as follows: Sample ComPound Example No. R 16 S 17 T 19 U 21(b) V 23(b) W 22(b) Table 5 GOT GPT AlP Bilirubin (K.U.) (K.U.) (K-AU.) (mg/dl) Control (normal) 78 # 3 30 # 3 25.7 # 0.4 0.10 # 0.00 CCl4 27875 # 3628 12984 # 1465 41.3 # 2.5 0.55 # 0.16 R + CCl4 425 # 124 260 # 98 31.4 # 1.6 0.16 # 0.02 S + CCl4 461 # 162 313 # 120 26.3 # 0.8 0.10 # 0.00 T + CCl4 5538 # 954 4156 # 196 34.4 # 1.7 0.25 # 0.03 U + CCl4 608 # 214 384 # 135 27.0 # 1.0 0.10 # 0.00 V + CCl4 2036 # 677 1251 # 414 35.6 # 1.4 0.15 # 0.03 Table 6 GOT GPT AlP Bilirubin (K.U.) (K.U.) (K-AU.) (mg/dl) Control (normal) 79 # 2 39 # 4 36.3 # 1.6 0.12 # 0.02 CCl4 23424 # 3360 12606 # 1688 52.5 # 2.2 0.50 # 0.08 W + CCl4 1194 # 234 805 # 195 49.5 # 3.0 0.20 # 0.00 Example 28 (Evaluation Example) Acute toxicity of the compounds according to the present invention LD50 values of the present compounds H, I, J, and L used in Example 26 were determined by observing SLC-Wistar male rats (5 weeks old and a body weight of 130 to 150 g) for one week after orally administering the sample compounds to be tested. The results were as follows: Compounds LD5o H more than 1000 mg/kg I more than 2000 mg/kg J more than 1000 mg/kg L more than 1000 mgXkg Example 29 (Evaluation Example) Acute toxicity of the compounds according to the present invention LD50 values of the present compounds A, F, O, R, and V used in Examples 26 and 27 were determined by observing SLC-Wistar male rats (5 weeks old and a body weight of 100 to 125 g) for one week after orally administering the sample compounds to be tested. The results were as follows: Compuonds LDso A more than 1000 mg/kg F more than 2000 mg/kg 0 more than 2000 mg/kg R more than 1500 mg/kg V more than 2000 mgZkg As is clear from the results shown in the above -mentioned Examples, the present 1,4-dihydropyridine compounds are effective for the treatment and prevention of hepatic disorders and also have a low toxicity. Accordingly, the present compounds are suitable for use as a medicine for treatment of hepatic disease caused by various factors.

Claims: CLAIMS 1. 1,4-Dihydropyridine compound having the general formula: EMI45.1 wherein R is 2-(5,6-dihydro-p-dioxinyl), 2-(3,5dimethyl-5,6-dihydro-p-dioxinyl), 2-(3-methyl-5,6dihydro-p-dioxinyl), 2-(3-methoxymethyl-5,6-dihydro-pdioxinyl), 5-(3,4-dihydro-2H-pyranyl), or 2-[5,6dihydro-1,4-dithiinyl) ; RÚ and Rê are independently a cyano group, an acetyl group, or a substituted oxycarbonyl group having the general formula COOR4 wherein R4 is a methyl, isopropyl, allyl, propargyl, methoxymethyl, 2-methoxyethyl, or l-methyl-2-methoxyethyl group provided that both R1 and R2 are not -COOCH3 in the case of R being 2-(5,6-dihydro-p-dioxinyl) and R being hydrogen; and R3 is hydrogen cr a :ttethcxy:rethyl group. 2. 1,4-Dihydropyridine compound as claimed in claim 1, wherein R is 2-(5,6-dihydro-p-dioxinyl) and R3 is hydrogen in the general formula (I). 3. 1,4-Dihydropyridine compound as claimed in claim 1, wherein R1 and R2 are independently an acetyl group or a substituted oxycarbonyl group having the general formula COOR4 wherein R4is a methyl, methoxymethyl, or 2-methoxyethyl group provided that both R1 and R2 are not -COOCH3 in the case of R being 3 2-(5,6-dihydro-p-dioxinyl) and R3 is hydrogen or a methoxymethyl group in the general formula (I). 4. 1,4-Dihydropyridine compound as claimed in claim 3, wherein R1 and R2 in the general formula (I) are the same groups. 5. 1,4-Dihydropyridine compound as claimed in claim 1, wherein R is 2-(5,6-dihydro-p-dioxinyl), 2-(3,5-drnethyl-5,6-dihydro-p-dioxinyl), 2- (3-methyl- 5,6-dihydro-p-dioxinyl), or 2-(3-methoxymethyl-5,6dihydro-p-dioxinyl), RÚ and Rê are independently an acetyl group or a substituted oxycarbonyl group having the general formula COOR4 wherein R is a methyl, methoxymethyl, or 2-methoxyethyl group provided that both RÚ and Rê are not -COOCH3 in the case of R being 2-(5,6-dihydro-p-dioxinyl) ; and R is hydrogen in the general formula 1I). 6. 1,4-Dihydropyridine compound as claimed in claim 5, wherein RÚ and Rê in the general formula (I) are the same group. 7. 1,4-Dihydropyridine compound as claimed in claim 6, wherein R is 2-(5,6-dihydro-p-dioxinyl) or 2-93,5-dimethyl-5,6-dihydro-p-dioxinyl) in the general formula (I). 8. 1,4-Dihydropyridine compound as claimed in claim 1, wherein R is 2-(5,6-dihydro-p-dioxinyl), 2-(3,5-dimethyl-5,6-dihydro-p-dioxinyl), 2-(3-methyl5,6-dihydro-p-dioxinyl), or 2-(3-methoxymethyl-5,6dihydrio-p-dioxinyl), both RÚ and Rê are an acetyl group or a substituted oxycarbonyl group having the general formula COOR4 wherein R4 is a methyl, methoxymethyl, or 2-methoxyethyl group; and R3 is a methoxymethyl group in the general formula (I). 9. 1,4-Dihydropyridine compound as claimed in claim 8, wherein R is 2-(5,6-dihydro-p-dioxinyl) or 2-(3,5-dimethyl-5,6-dihydro-p-dioxinyl) in the general formula (I). 10. 1,4-Dihydropyridine compound as claimed in claim 8, wherein R is 2-(5,6-dihydro-p-dioxinyl) in the general formula (I). 11. 1,4-Dihydropyridine compound as claimed in claim 5, wherein R is 2-(5,6-dihydro-p-dioxinyl) and R1 and R2 are the same groups in the general formula (I). 12. 1,4-Dihydropyridine compound as claimed in claim 2, wherein R1 and Rê are the same groups in the general formula (I).

Inventors: INOUE, YOICHI, IWAMOTO, MITSUO, MATSUMOTO, TOSHIO, MOTOYOSHI, YOSHIE, NIWA, HIROSUKE, SHIRAISHI, TAKANORI, SUZUKI, KENICHI, YOSHIDA, YOHJI
Applicants: INSTITUTE OF ORGANIC SYNTHESIS  ACADEMY OF SCIENCES LATVIAN SSR., NIKKEN CHEMICALS CO., LTD.
Application year: 1984
Main classification: C07D405
IPC codes: C07D319, C07D409, C07D339, C07D405